Pramipexole
Showing 1 - 25 of 180
Anhedonia, Depression Trial in Lund (Pramipexole)
Not yet recruiting
- Anhedonia
- Depression
- Pramipexole
-
Lund, Scania, SwedenRegion Skåne
Apr 10, 2023
Psychiatric Disorders Mood, Anhedonia, Depression Trial in Lund (Pramipexole, Placebo)
Not yet recruiting
- Psychiatric Disorders Mood
- +2 more
- Pramipexole
- Placebo
-
Lund, SwedenRegion Skåne
Jan 2, 2023
Extrapyramidal Syndrome Trial in Shanghai (Pramipexole, Trihexyphenidyl HCl)
Completed
- Extrapyramidal Syndrome
- Pramipexole
- Trihexyphenidyl hydrochloride
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Jun 24, 2022
OCD Trial (Pramipexole, Risperidone)
Not yet recruiting
- Obsessive-Compulsive Disorder
- Pramipexole
- Risperidone
- (no location specified)
May 27, 2022
Restless Legs Syndrome Trial in Beijing (Pramipexole, )
Terminated
- Restless Legs Syndrome
- Pramipexole
- placebo
-
Beijing, ChinaPeking University First Hospital
Nov 28, 2021
Depression, Bipolar, Depression, Unipolar, Dysthymia Trial in Lund (Pramipexole Pill)
Completed
- Depression, Bipolar
- +3 more
- Pramipexole Pill
-
Lund, SwedenPsychiatry Clinic, Lund, Region Skåne
Sep 14, 2021
Alzheimer's Disease Trial in Kansas City (R-pramipexole)
Completed
- Alzheimer's Disease
-
Kansas City, KansasUniversity of Kansas Medical Center
Sep 15, 2021
Parkinson Disease Trial in Nashville (Pramipexole, Placebo)
Recruiting
- Parkinson Disease
- Pramipexole
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
May 2, 2022
Sleep Disorder, Restless Legs Syndrome, Opioid-use Disorder Trial in Boston, Quincy (Pramipexole, Placebo)
Not yet recruiting
- Sleep Disorder
- +3 more
- Pramipexole
- Placebo
-
Boston, Massachusetts
- +1 more
Aug 31, 2021
Treatment Resistant Depression Trial in Bhubaneswar (Quetiapine, Amantadine, Pramipexole)
Not yet recruiting
- Treatment Resistant Depression
- Quetiapine
- +2 more
-
Bhubaneswar, Orissa, IndiaAll India Institute of Medical Sciences
Jun 26, 2021
MDD (MDD) Trial in Long Beach (CTC-501)
Active, not recruiting
- Major Depressive Disorder (MDD)
-
Long Beach, CaliforniaCollaborative Neuroscience Network
Apr 22, 2022
(Research on Anxiety and Depression - Anhedonia Treatment)
Enrolling by invitation
- Anxiety
- Depression
- Pramipexole Oral Tablet
-
Los Altos, California
- +2 more
Jan 7, 2022
Parkinson Disease Trial in China (Pramipexole SR, Pramipexole IR)
Completed
- Parkinson Disease
- Pramipexole SR
- Pramipexole IR
-
Beijing, China
- +11 more
Feb 8, 2021
Adrenoleukodystrophy, Restless Legs Syndrome Trial in Boston, Amsterdam (Pramipexole, Placebo)
Not yet recruiting
- Adrenoleukodystrophy
- Restless Legs Syndrome
- Pramipexole
- Placebo
-
Boston, Massachusetts
- +1 more
Aug 5, 2021
Parkinson's Disease Trial in Hanzhou (Praxol HCl sustained release tablet Specification: 0.375mg/ tablet (in pramipexole HCl),
Unknown status
- Parkinson's Disease
- Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride)
- Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole)
-
Hanzhou, Zhejiang, ChinaThe First Affiliated Hospital,ZheJiang Univercity
Sep 7, 2020
Gait Analysis in Neurological Disease
Active, not recruiting
- Parkinson's Disease
- +7 more
- Anti-Parkinson medication
- Deep Brain Stimulation
-
Boston, MassachusettsClinical Research Center BIDMC
Jul 20, 2021
Parkinson Disease Trial in Multiple Locations (KDT-3594, Pramipexole)
Completed
- Parkinson Disease
- KDT-3594
- Pramipexole
-
Multiple Locations, JapanResearch Site
Feb 16, 2021
Emotions, Motivation, Reward Trial in Oxford (Pramipexole, Placebo)
Completed
- Emotions
- +3 more
- Pramipexole
- Placebo
-
Oxford, Oxfordshire, United KingdomDept of Psychiatry, University of Oxford
Mar 23, 2020
Parkinson Disease, Early Parkinson's Disease Trial in Worldwide (P2B001, Rasagiline, Pramipexole)
Active, not recruiting
- Parkinson Disease
- Early Parkinson's Disease
- P2B001
- +3 more
-
Scottsdale, Arizona
- +71 more
May 20, 2021
Restless Legs Syndrome Trial in United States (pregabalin, , pramipexole)
Bipolar Disorder Trial in Boston, Glen Oaks, New York (Pramipexole, Placebo)
Completed
- Bipolar Disorder
- Pramipexole
- Placebo
-
Boston, Massachusetts
- +2 more
Feb 14, 2020
PTSD, MDD Trial in New York (PE/Pramipexole)
Terminated
- PTSD
- MDD
- PE/Pramipexole
-
New York, New YorkNew York State Psychiatric Institute
Nov 7, 2019
Renal Colic Trial in Greenville (Pramipexole, Morphine, Placebo oral tablet)
Unknown status
- Renal Colic
- Pramipexole
- +2 more
-
Greenville, North CarolinaVidant Medical Center ED
Nov 8, 2019
MDD Trial in New York (Pramipexole)
Completed
- Major Depressive Disorder
- Pramipexole
-
New York, New YorkNew York State Psychiatric Institute
Oct 30, 2019
Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Attack Trial in United States (Dexpramipexole DiHCl, Placebo)
Recruiting
- Eosinophilic Asthma
- +2 more
- Dexpramipexole Dihydrochloride
- Placebo
-
West Covina, California
- +7 more
Mar 1, 2023